Skip to main content

Howard Goldstein

Premium

Howard Goldstein has become senior vice president of sales and marketing, a newly created position, at Seattle-based Amnis.

Most recently, he was senior vice president for sales, service, and marketing at Argonaut Technologies. In the past, he held sales and marketing positions at Incyte Genomics, Molecular Devices, Molecular Dynamics, and Applied Biosystems.

Goldstein received an MBA from Temple University, an MS in biochemistry from the University of Dayton, and a BS in biology from Bucknell University.

In an official company statement dated June 30, Jack Ball, Amnis’ president and CEO, said “having an individual of Howard’s stature and broad experience as a member of the Amnis management team supports moving the company to the next stage and marks our formal transition to full commercial release of the ImageStream 100 system.”

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.